Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Clozapine.

Książki na temat „Clozapine”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Clozapine”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

author, Taylor David, ed. Clozapine handbook. Lloyd-Reinhold Communications, 2013.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

1941-, Jones Barry, Lapierre Yvon D, Canadian Psychiatric Association Meeting, Royal Society of Medicine Services (Great Britain), and Sandoz Canada, eds. Clozapine in treatment-resistant schizophrenia: A scientific update. Royal Society of Medicine Services, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Y, Meltzer Herbert, ed. Clozapine: A 5-year perspective and clinical recommendations. Physicians Postgraduate Press, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Glennie, Judith. Pharmacoeconomic evaluations of clozapine in treatment-resistant schizophrenia and risperidone in chronic schizophrenia. Canadian Coordinating Office for Health Technology Assessment, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Lundberg, Tommie. Clozapine - an atypical neoroleptic: A pharmacokinetic, PET and clinical study. Uppsala University, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Masellis, Mario. Pharmacogenetic analysis of serotonin receptors and clinical response to clozapine in schizophrenia patients. National Library of Canada = Bibliothèque nationale du Canada, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Naber, D., F. Müller-Spahn, and F. G. Pajonk, eds. Clozapin. Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60551-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

1954-, Watkins Linda R., and Maier Steven F, eds. Cytokines and pain. Birkhauser Verlag, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights. Marketing of Clozaril: Improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991. U.S. G.P.O., 1991.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Naber, Dieter, and Franz Müller-Spahn, eds. Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums. Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-93547-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Naber, Dieter, and Franz Müller-Spahn, eds. Clozapin Pharmakologie und Klinik eines atypischen Neuroleptikums. Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-93565-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Sirfy, Ahmad. Dopamimetische Psychose bei Patienten mit idiopathischem Parkinson-Syndrom und verwandten Erkrankungen - eine retrospektive Analyse der Clozapin-Plasmaspiegel, der Dosis-Spiegel-Relation und Einflussfaktoren auf die Clozapin-Plasmaspiegel bei bestehender Clozapin-Medikation. s.n.], 2013.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Clozapine: The atypical antipsychotic. Royal College of Psychiatrists, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Meyer, Jonathan M., and Stephen M. Stahl. Clozapine Handbook: Stahl's Handbooks. University of Cambridge ESOL Examinations, 2021.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Clozapine Handbook: Stahl's Handbooks. Cambridge University Press, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Lane, Chadrick, and Vinod H. Srihari. Clozapine for Treatment-Resistant Schizophrenia. Edited by Ish P. Bhalla, Rajesh R. Tampi, Vinod H. Srihari, and Michael E. Hochman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190625085.003.0040.

Pełny tekst źródła
Streszczenie:
This chapter provides a summary of a landmark study on the pharmacologic management of treatment-resistant schizophrenia. This clinical trial, conducted by Kane and colleagues, asks whether clozapine is an effective option in the care of patients with treatment-resistant schizophrenia who have not responded to past trials of first-generation antipsychotics. To answer this question, the chapter reviews the basics of the study, including funding sources, study location, inclusion and exclusion criteria, number of participants, research design, interventions, follow-up, endpoints, results, critic
Style APA, Harvard, Vancouver, ISO itp.
17

Barron, Daniel, and Noah Capurso. Clozapine for Suicidality in Schizophrenia. Edited by Ish P. Bhalla, Rajesh R. Tampi, Vinod H. Srihari, and Michael E. Hochman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190625085.003.0046.

Pełny tekst źródła
Streszczenie:
Patients with schizophrenia have a 50% risk of a suicide attempt during their life, with a nearly an estimated 10% risk of completed suicide. Decreasing this risk is an urgent clinical concern. This chapter provides a summary of a landmark study on how to reduce suicidality in patients with schizophrenia, specifically whether clozapine reduces suicidal events in patients with schizophrenia. This chapter describes the outline of the study, including fundings sources, study locations, the patient population and how many were studied, the study design and intervention through to follow-up, endpoi
Style APA, Harvard, Vancouver, ISO itp.
18

Rohde, Christopher, and Jimmi Nielsen. Managing common adverse effects of clozapine. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0007.

Pełny tekst źródła
Streszczenie:
Adverse effects during clozapine treatment are common, and can be divided into very common (>10%: constipation, weight gain, metabolic side effects, sedation, and sialorrhea), common (1–10%: seizures and enuresis), and cardiac (sinus tachycardia, electrocardiogram abnormalities, and orthostatic hypotension) adverse effects. Most adverse effects are benign, but often reduce the quality of life for the patient, leading to reduced adherence and thereby psychotic relapse. As a consequence, treatment of these adverse effects is important and should not be neglected. In this chapter, we present s
Style APA, Harvard, Vancouver, ISO itp.
19

Leponex: Informationen für Betroffene, ihre Angehörigen und Freunde. Pm-Verlag, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Yuen, Eunice, and Cenk Tek. Effectiveness of Clozapine versus Other Atypical Antipsychotics. Edited by Ish P. Bhalla, Rajesh R. Tampi, Vinod H. Srihari, and Michael E. Hochman. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190625085.003.0041.

Pełny tekst źródła
Streszczenie:
This chapter provides a summary of a landmark study on adult patients with schizophrenia. Discussion here is based on the investigation from the Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE). What is the role of clozapine among patients with chronic schizophrenia who fail to respond to atypical antipsychotics? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews oth
Style APA, Harvard, Vancouver, ISO itp.
21

Lerner, Vladimir. Clozapine: Medical Uses, Interactions and Side Effects. Nova Science Publishers, Incorporated, 2020.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Chanoch, Miodownik, Amir Krivoy, and Vladimir Lerner. Clozapine: Medical Uses, Interactions and Side Effects. Nova Science Publishers, Incorporated, 2020.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Brown, Julia. Clozapine Clinic: Health Agency in High-Risk Conditions. Taylor & Francis Group, 2022.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Brown, Julia E. H. Clozapine Clinic: Health Agency in High-Risk Conditions. Routledge, 2022.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Brown, Julia. Clozapine Clinic: Health Agency in High-Risk Conditions. Taylor & Francis Group, 2022.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Brown, Julia. Clozapine Clinic: Health Agency in High-Risk Conditions. Taylor & Francis Group, 2022.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Yang, Yvonne, and Stephen Marder. Pharmacological management of treatment-resistant schizophrenia: fundamentals of clozapine. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0006.

Pełny tekst źródła
Streszczenie:
Evidence from controlled clinical trials supports the prescribing of clozapine for patients with treatment-resistant schizophrenia (TRS). Early studies focused on severely ill TRS patients. More recent studies indicate that clozapine can be effective for patients who are relatively stable but are burdened by persistent psychotic symptoms. Clozapine treatment is associated with a substantial side effect burden, including sedation, orthostasis, weight gain, constipation, and seizures. In addition, because of a risk of potentially fatal agranulocytosis, clozapine patients require regular monitori
Style APA, Harvard, Vancouver, ISO itp.
28

Barnes, Thomas R. E. Pharmacological management of treatment-resistant schizophrenia: alternatives to clozapine. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0009.

Pełny tekst źródła
Streszczenie:
Other than for clozapine, there are no pharmacological interventions with robust evidence of a positive benefit–risk balance for the treatment-resistant schizophrenia. For patients with treatment-resistant schizophrenia, there is usually little to be gained, in comparison to switching the antipsychotic to clozapine, from alternatives such as a further switch to a non-clozapine antipsychotic medication, the prescription of high-dose or combined antipsychotic medications, or the augmentation of continuing antipsychotic medication with other medications, such as antidepressants, mood stabilizers,
Style APA, Harvard, Vancouver, ISO itp.
29

Clozapine congeners: Structural requirements for dopamine D4 receptor selectivity. National Library of Canada = Bibliothèque nationale du Canada, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Gee, Siobhan, and David Taylor. Pharmacological management of treatment-resistant schizophrenia: advanced use of clozapine. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0008.

Pełny tekst źródła
Streszczenie:
Clozapine is licensed in the UK for use in treatment-resistant schizophrenia, treatment-intolerant schizophrenia, or psychosis associated with Parkinson’s disease. As with many drugs, it is also used outside of these licensing parameters for other conditions or clinical situations—often referred to as ‘off-label’ prescribing. These off-label indications have varying degrees of theoretical support, peer-reviewed evidence, and practical experience associated with them. This chapter discusses the use of clozapine for children and adolescents, older adults, and in the treatment of aggression and m
Style APA, Harvard, Vancouver, ISO itp.
31

Lapierre, Y. Clozapine in Treatment-resistant Schizophrenia: A Scientifid Update (International Congress & Symposium). Royal Society of Medicine Press Ltd, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Publications, ICON Health. Clozapine - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Bond, Stephen. Impact of the pharmacist on resource utilization in an outpatient adult clozapine clinic. 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Rowling, Corene. CLOZAPINE: A Prescription Drug Used to Treat a Schizoaffective Disorders or Psychotic Mood Issue. Independently Published, 2019.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Remington, Gary, Ofer Agid, Hiroyoshi Takeuchi, Jimmy Lee, and Araba Chintoh. Ultra-treatment resistance. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0012.

Pełny tekst źródła
Streszczenie:
Ultra-treatment resistance or ultra-resistant schizophrenia is defined as describing individuals who meet criteria for treatment-resistant schizophrenia and receive an adequate trial of clozapine in the absence of other confounding factors that might compromise response (e.g. substance abuse, antipsychotic non-adherence), but demonstrate a suboptimal response. Because the definition currently hinges on a trial of clozapine, ‘clozapine-resistant schizophrenia’ has also been proposed as a more precise descriptor. This chapter reviews issues specific to classifying this subpopulation, including e
Style APA, Harvard, Vancouver, ISO itp.
36

Howes, Oliver, ed. Treatment Response and Resistance in Schizophrenia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.001.0001.

Pełny tekst źródła
Streszczenie:
Schizophrenia and other psychotic disorders are common mental illnesses, but their treatment is complex. This book provides a state-of-the-art overview of their treatment, with a focus on the real-world challenges faced by clinicians and patients. It brings together contributions from leading experts from around the world to cover key conceptual issues, including how to evaluate response, the nature of treatment resistance, ultra-medication (clozapine) treatment resistance, and pseudo-resistance, and how to choose a first-line antipsychotic drug that maximizes response and minimizes side effec
Style APA, Harvard, Vancouver, ISO itp.
37

Hwang, Rudi. Pharmacogenetic analysis of dopamine receptor gene polymorphisms and clinical response to clozapine in patients with schizophrenia. 2006.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Abbas, Atheir I., and Jeffrey A. Lieberman. Pharmacological Treatments for Schizophrenia. Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780199342211.003.0006.

Pełny tekst źródła
Streszczenie:
Schizophrenia, a chronic mental disorder, has a lifetime prevalence rate of approximately 1%. The first antipsychotic drug, chlorpromazine, was introduced in 1954, followed by several similar drugs. With the introduction of clozapine, risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole, and more recently paliperidone, iloperidone, asenapine, and lurasidone, antipsychotic drugs are often classified as first generation or typical (chlorpromazine-like) versus second generation or atypical (clozapine-like), although the distinction between the two classes, particularly with respect to e
Style APA, Harvard, Vancouver, ISO itp.
39

Smith, Robert C., Stefan Leucht, and John M. Davis. Maximizing response to first-line antipsychotics in schizophrenia. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198828761.003.0003.

Pełny tekst źródła
Streszczenie:
The choice of first-line antipsychotic treatment for patients with schizophrenia should balance considerations of differential efficacy of antipsychotics against the relative risk of different side effects. In terms of efficacy, recent meta-analyses have shown that antipsychotics are not equivalent in efficacy. Clozapine, amisulpride, olanzapine, and risperidone show small to moderate, but statistically significant, differences, indicating greater efficacy compared to a number of other antipsychotics on some primary efficacy outcome measures. Amisulpride and cariprazine have the strongest evid
Style APA, Harvard, Vancouver, ISO itp.
40

Burns, Tom, and Mike Firn. The role of medication. Edited by Tom Burns and Mike Firn. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198754237.003.0007.

Pełny tekst źródła
Streszczenie:
This chapter focuses mainly on the importance of maintenance antipsychotic medication and mood stabilizers. It examines procedures to support persistence with these drugs and maintain engagement. The techniques for initiating and monitoring clozapine therapy in the community for patients with resistant schizophrenia are outlined. The practical processes for ensuring and conducting regular structured reviews of long-term medication, both to assess progress and to identify side effects, are described in detail. In addition, the judicious use of antidepressants and benzodiazepines is outlined.
Style APA, Harvard, Vancouver, ISO itp.
41

Burns, Tom, and Mike Firn. Schizophrenia and delusional disorders. Edited by Tom Burns and Mike Firn. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198754237.003.0015.

Pełny tekst źródła
Streszczenie:
Schizophrenia is the iconic mental illness. This chapter describes the evolution of the concept by doctors in the early mental hospitals through to modern classifications of its subtypes. The nature/nurture controversy has been particularly fraught in schizophrenia and the possible role of the family in its genesis is considered in detail. Explanatory models such as the ‘schizophrenogenic mother’ and the ‘double bind’, although now only historical, are described because of their hold on the popular imagination. Family factors (‘expressed emotion’) in the maintenance of the disorder are also co
Style APA, Harvard, Vancouver, ISO itp.
42

Schulz, S. Charles, and Robert O. Friedel. Established and Novel Pharmacological Approaches to the Treatment of Personality Disorders. Edited by Christian Schmahl, K. Luan Phan, Robert O. Friedel, and Larry J. Siever. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199362318.003.0016.

Pełny tekst źródła
Streszczenie:
In the past few decades, the widely held belief of personality disorder patients being unresponsive to medication has been challenged. This chapter first reviews the current knowledge on medication for patients with personality disorders and then considers a number of novel pharmacological approaches that may yield additional beneficial results in the treatment of these disorders. It utilizes the neuroscience-based nomenclature for psychotropic agents, in which the presumptive modes and mechanisms of action of each drug form the basis of the nomenclature. A special emphasis of the chapter is l
Style APA, Harvard, Vancouver, ISO itp.
43

Ellison, Justin C., Jason B. Rosenstock, and Michael J. Marcsisin. Somatic Treatments for Psychotic Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199331505.003.0006.

Pełny tekst źródła
Streszczenie:
A variety of somatic therapies can be used to treat individuals suffering from psychosis. Most commonly, providers will prescribe antipsychotics, which generally block dopamine receptors and are particularly useful at reducing positive symptoms. Second-generation antipsychotics have fewer movement side effects than older agents do, but they are more expensive and have more metabolic side effects. Long-acting injectable (LAI) antipsychotics can be useful for improving outcomes, especially in non-adherent patients, and clozapine is the gold standard for treatment-refractory psychosis. Other agen
Style APA, Harvard, Vancouver, ISO itp.
44

Rose, Raquel, and Nicolette Molina. Interventions. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190260859.003.0010.

Pełny tekst źródła
Streszczenie:
Despite the fact that suicide is one of the leading causes of death in the United States, there are currently no US Food and Drug Administration-approved treatments for suicidal behavior. However, interventions that provide potentially effective treatment are available. This chapter explores medications and biological interventions as well as psychosocial, alternative, and app/Internet-based interventions. The section on medications and biological interventions covers clozapine, lithium, and ketamine. The psychosocial intervention section covers dialectical behavior therapy, cognitive–behavior
Style APA, Harvard, Vancouver, ISO itp.
45

Douglas, Kevin S., Tonia L. Nicholls, and Johann Brink. Interventions for the Reduction of Violence by Persons with Serious Mental Illnesses. Edited by Phillip M. Kleespies. Oxford University Press, 2016. http://dx.doi.org/10.1093/oxfordhb/9780199352722.013.34.

Pełny tekst źródła
Streszczenie:
Violence perpetrated by persons with serious mental illness (SMI), although certainly not the norm among this group, is of clinical and legal import in numerous legal settings. Among these are civil commitment, forensic psychiatry (insanity acquittees), and the criminal justice system. In this chapter, we provide a critical review of interventions and their empirical support that are used to reduce violence among persons with SMI. Promising findings support the use of cognitive behavioral, social learning, and cognitive skills approaches that are consistent with the Risk-Need-Responsivity (RNR
Style APA, Harvard, Vancouver, ISO itp.
46

Tracy, Derek K., and Fiona Gaughran. Treatment with medication: Side effects, adherence, and risk. Edited by Alec Buchanan and Lisa Wootton. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198738664.003.0009.

Pełny tekst źródła
Streszczenie:
Antipsychotic medications revolutionized the care of psychosis, but they have brought with them significant side effects and issues around adherence; these latter factors, and informed co-working with patients, are primary drivers for specific medication choices. The data remain limited for polypharmacy and above-maximum dose prescribing, though there may be individuals for whom this is considered. Long-acting injectables (LAIs or ‘depots’) have a good evidence base, and are probably underutilized, though clozapine remains our drug of choice in refractory illness. Forensic-population data show
Style APA, Harvard, Vancouver, ISO itp.
47

(Editor), Bart A. Ellenbroek, and Alexander R. Cools (Editor), eds. Atypical Antipsychotics (Milestones in Drug Therapy). Birkhäuser Basel, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Beiner, Heike Anne-Marie. Auswirkungen von Clozapin auf das Elektroenzephalogramm. 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Kückelmann, Stephan. Zur Wirksamkeit von Clozapin bei Spätdyskinesien. 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Leppig, Manuela. Zur Wirksamkeit von Clozapin bei ambulanter Langzeitbehandlung. 1989.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!